UNSPSC 51343828: Darunavir/Ritonavir

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM800. This VA Drug Class (AM800) classifies this compound as belonging to the group ANTIVIRALS.

UNSPSC 51343828 Darunavir/Ritonavir is a Commodity code for a specific antiretroviral pharmaceutical product, but the recent state and local opportunities tagged under this code do not align with its nominal scope. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets—antibiotics, not antiretrovirals. Seminole County, Florida released an IFB on June 30, 2026 for Naloxone and Safe Drug Deactivation Systems, a harm-reduction procurement unrelated to antiviral therapy. The code shows little relevant recent activity aligned with darunavir/ritonavir procurement; the opportunities posted under this classification appear to reflect mistagging by the issuing bodies rather than actual buying patterns for the specified drug.

The geographic spread evident in the recent records spans Illinois and Florida, though both opportunities represent misaligned commodity classifications. The Illinois award to Chartwell Rx LLC carried a three-year contract value of $2,999,999.11 with an initial 12-month term and renewal options. Seminole County's IFB called for 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries, a two-year initial term and one-year renewal option, and FEMA funding contingency. Without opportunities correctly tagged to antiretroviral procurement, this code does not currently offer a clear signal for vendors focused on darunavir/ritonavir supply to state and local health agencies.